A citation-based method for searching scientific literature

Mitch Dowsett, Torsten O Nielsen, Roger A'Hern, John Bartlett, R Charles Coombes, Jack Cuzick, Matthew Ellis, N Lynn Henry, Judith C Hugh, Tracy Lively, Lisa McShane, Soon Paik, Frederique Penault-Llorca, Ljudmila Prudkin, Meredith Regan, Janine Salter, Christos Sotiriou, Ian E Smith, Giuseppe Viale, Jo Anne Zujewski, Daniel F Hayes. J Natl Cancer Inst 2011
Times Cited: 1071

List of co-cited articles
377 articles co-cited >1

Times Cited
  Times     Co-cited

An international Ki67 reproducibility study.
Mei-Yin C Polley, Samuel C Y Leung, Lisa M McShane, Dongxia Gao, Judith C Hugh, Mauro G Mastropasqua, Giuseppe Viale, Lila A Zabaglo, Frédérique Penault-Llorca, John M S Bartlett,[...]. J Natl Cancer Inst 2013

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, Della F Makower, Kathleen I Pritchard, Kathy S Albain, Daniel F Hayes, Charles E Geyer, Elizabeth C Dees, Matthew P Goetz, John A Olson,[...]. N Engl J Med 2018

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, Mitch Dowsett, Lisa M McShane, Kimberly H Allison, Donald C Allred, John M S Bartlett, Michael Bilous, Patrick Fitzgibbons,[...]. J Clin Oncol 2013

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000

Ki67 in breast cancer: prognostic and predictive potential.
Rinat Yerushalmi, Ryan Woods, Peter M Ravdin, Malcolm M Hayes, Karen A Gelmon. Lancet Oncol 2010

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L Baehner, Michael G Walker, Drew Watson, Taesung Park,[...]. N Engl J Med 2004

Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration.
Samuel C Y Leung, Torsten O Nielsen, Lila Zabaglo, Indu Arun, Sunil S Badve, Anita L Bane, John M S Bartlett, Signe Borgquist, Martin C Chang, Andrew Dodson,[...]. NPJ Breast Cancer 2016

Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up.
Sara Bustreo, Simona Osella-Abate, Paola Cassoni, Michela Donadio, Mario Airoldi, Fulvia Pedani, Mauro Papotti, Anna Sapino, Isabella Castellano. Breast Cancer Res Treat 2016

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients.
E de Azambuja, F Cardoso, G de Castro, M Colozza, M S Mano, V Durbecq, C Sotiriou, D Larsimont, M J Piccart-Gebhart, M Paesmans. Br J Cancer 2007

Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.
A S Coates, E P Winer, A Goldhirsch, R D Gelber, M Gnant, M Piccart-Gebhart, B Thürlimann, H-J Senn. Ann Oncol 2015

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.
Antonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, Brittany E Harvey, Pamela B Mangu, John M S Bartlett, Michael Bilous, Ian O Ellis, Patrick Fitzgibbons, Wedad Hanna,[...]. J Clin Oncol 2018

An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer.
David L Rimm, Samuel C Y Leung, Lisa M McShane, Yalai Bai, Anita L Bane, John M S Bartlett, Jane Bayani, Martin C Chang, Michelle Dean, Carsten Denkert,[...]. Mod Pathol 2019

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update.
Kimberly H Allison, M Elizabeth H Hammond, Mitchell Dowsett, Shannon E McKernin, Lisa A Carey, Patrick L Fitzgibbons, Daniel F Hayes, Sunil R Lakhani, Mariana Chavez-MacGregor, Jane Perlmutter,[...]. J Clin Oncol 2020

Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study.
Balazs Acs, Vasiliki Pelekanou, Yalai Bai, Sandra Martinez-Morilla, Maria Toki, Samuel C Y Leung, Torsten O Nielsen, David L Rimm. Lab Invest 2019

An international study to increase concordance in Ki67 scoring.
Mei-Yin C Polley, Samuel C Y Leung, Dongxia Gao, Mauro G Mastropasqua, Lila A Zabaglo, John M S Bartlett, Lisa M McShane, Rebecca A Enos, Sunil S Badve, Anita L Bane,[...]. Mod Pathol 2015

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, Steven Shak, Chungyeul Kim, Joffre Baker, Wanseop Kim, Maureen Cronin, Frederick L Baehner, Drew Watson, John Bryant,[...]. J Clin Oncol 2006

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.
Fatima Cardoso, Laura J van't Veer, Jan Bogaerts, Leen Slaets, Giuseppe Viale, Suzette Delaloge, Jean-Yves Pierga, Etienne Brain, Sylvain Causeret, Mauro DeLorenzi,[...]. N Engl J Med 2016

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
C Davies, J Godwin, R Gray, M Clarke, D Cutter, S Darby, P McGale, H C Pan, C Taylor, Y C Wang,[...]. Lancet 2011

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group.
Torsten O Nielsen, Samuel C Y Leung, David L Rimm, Andrew Dodson, Balazs Acs, Sunil Badve, Carsten Denkert, Matthew J Ellis, Susan Fineberg, Margaret Flowers,[...]. J Natl Cancer Inst 2021

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
G Curigliano, H J Burstein, E P Winer, M Gnant, P Dubsky, S Loibl, M Colleoni, M M Regan, M Piccart-Gebhart, H-J Senn,[...]. Ann Oncol 2017

Proliferation marker Ki-67 in early breast cancer.
Ander Urruticoechea, Ian E Smith, Mitch Dowsett. J Clin Oncol 2005

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.
R Peto, C Davies, J Godwin, R Gray, H C Pan, M Clarke, D Cutter, S Darby, P McGale, C Taylor,[...]. Lancet 2012

Strategies for developing Ki67 as a useful biomarker in breast cancer.
Carsten Denkert, Jan Budczies, Gunter von Minckwitz, Stephan Wienert, Sibylle Loibl, Frederick Klauschen. Breast 2015

Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer.
Frédérique Penault-Llorca, Fabrice André, Christine Sagan, Magali Lacroix-Triki, Yves Denoux, Veronique Verriele, Jocelyne Jacquemier, Marie Christine Baranzelli, Frederic Bibeau, Martine Antoine,[...]. J Clin Oncol 2009

Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance).
Matthew J Ellis, Vera J Suman, Jeremy Hoog, Rodrigo Goncalves, Souzan Sanati, Chad J Creighton, Katherine DeSchryver, Erika Crouch, Amy Brink, Mark Watson,[...]. J Clin Oncol 2017

Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.
Mitch Dowsett, Ian E Smith, Stephen R Ebbs, J Michael Dixon, Anthony Skene, Roger A'Hern, Janine Salter, Simone Detre, Margaret Hills, Geraldine Walsh. J Natl Cancer Inst 2007

Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer.
Jack Cuzick, Mitch Dowsett, Silvia Pineda, Christopher Wale, Janine Salter, Emma Quinn, Lila Zabaglo, Elizabeth Mallon, Andrew R Green, Ian O Ellis,[...]. J Clin Oncol 2011

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, D Craig Allred, Karen L Hagerty, Sunil Badve, Patrick L Fitzgibbons, Glenn Francis, Neil S Goldstein, Malcolm Hayes,[...]. J Clin Oncol 2010

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.
Patricia Cortazar, Lijun Zhang, Michael Untch, Keyur Mehta, Joseph P Costantino, Norman Wolmark, Hervé Bonnefoi, David Cameron, Luca Gianni, Pinuccia Valagussa,[...]. Lancet 2014

Ki-67 acts as a biological surfactant to disperse mitotic chromosomes.
Sara Cuylen, Claudia Blaukopf, Antonio Z Politi, Thomas Müller-Reichert, Beate Neumann, Ina Poser, Jan Ellenberg, Anthony A Hyman, Daniel W Gerlich. Nature 2016

High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in luminal B HER2 negative and node-positive breast cancer.
Carmen Criscitiello, Davide Disalvatore, Michele De Laurentiis, Lucia Gelao, Luca Fumagalli, Marzia Locatelli, Vincenzo Bagnardi, Nicole Rotmensz, Angela Esposito, Ida Minchella,[...]. Breast 2014

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001

Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial.
C Denkert, S Loibl, B M Müller, H Eidtmann, W D Schmitt, W Eiermann, B Gerber, H Tesch, J Hilfrich, J Huober,[...]. Ann Oncol 2013

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.
Kathy S Albain, William E Barlow, Steven Shak, Gabriel N Hortobagyi, Robert B Livingston, I-Tien Yeh, Peter Ravdin, Roberto Bugarini, Frederick L Baehner, Nancy E Davidson,[...]. Lancet Oncol 2010

Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis.
Molly E Klein, David J Dabbs, Yongli Shuai, Adam M Brufsky, Rachel Jankowitz, Shannon L Puhalla, Rohit Bhargava. Mod Pathol 2013

Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration.
Samuel C Y Leung, Torsten O Nielsen, Lila A Zabaglo, Indu Arun, Sunil S Badve, Anita L Bane, John M S Bartlett, Signe Borgquist, Martin C Chang, Andrew Dodson,[...]. Histopathology 2019

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018

Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry.
E C Inwald, M Klinkhammer-Schalke, F Hofstädter, F Zeman, M Koller, M Gerstenhauer, O Ortmann. Breast Cancer Res Treat 2013

The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer.
Robin L Jones, Janine Salter, Roger A'Hern, Ash Nerurkar, Marina Parton, Jorge S Reis-Filho, Ian E Smith, Mitchell Dowsett. Breast Cancer Res Treat 2009

Standardized Ki67 Diagnostics Using Automated Scoring--Clinical Validation in the GeparTrio Breast Cancer Study.
Frederick Klauschen, Stephan Wienert, Wolfgang D Schmitt, Sibylle Loibl, Bernd Gerber, Jens-Uwe Blohmer, Jens Huober, Thomas Rüdiger, Erhard Erbstößer, Keyur Mehta,[...]. Clin Cancer Res 2015

Ki67 measured after neoadjuvant chemotherapy for primary breast cancer.
Gunter von Minckwitz, Wolfgang D Schmitt, Sibylle Loibl, Berit M Müller, Jens U Blohmer, Bruno V Sinn, Holger Eidtmann, Wolfgang Eiermann, Bernd Gerber, Hans Tesch,[...]. Clin Cancer Res 2013

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
F Cardoso, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, I T Rubio, S Zackrisson, E Senkus. Ann Oncol 2019

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.
Antonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, Karen L Hagerty, D Craig Allred, Richard J Cote, Mitchell Dowsett, Patrick L Fitzgibbons, Wedad M Hanna, Amy Langer,[...]. J Clin Oncol 2007

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.